Pancreatic Cancer

Our multidisciplinary team delivers personalized pancreatic cancer treatment and is actively investigating methods to improve early diagnosis and treatment.

No two pancreatic cancer diagnoses are alike. We work with patients and their referring provider to craft treatment plans that meet the needs of each individual patient’s diagnosis, taking into consideration the stage of his or her cancer, medical history, age and personal preferences.


Treatment options for pancreatic cancer patients may include:

  • Whipple procedure
  • Total pancreatectomy
  • Distal pancreatectomy
  • Chemotherapy
  • Radiation therapy
  • Surgical oncology
  • Pain management
  • Palliative care
  • Investigational treatments available through clinical research trials

Ongoing Clinical Research Trials

Hoping to provide a more personalized treatment plan for pancreatic cancer, two studies at Baylor University Medical Center, part of Baylor Scott & White Health, are focused on identifying more precise biomarkers for the early detection, disease monitoring and effective treatment for pancreatic cancer.

Specialized Centers

While several Baylor Scott & White Health locations treat patients who have pancreatic cancer, two specialized centers for pancreatic cancer care provide enhanced services in this area.

The Pancreatic Cancer Research and Treatment Center at Baylor Charles A. Sammons Cancer Center at Baylor University Medical Center, part of Baylor Scott & White Health, specializes in advanced cancer care and research in its pursuit of a cure for pancreatic cancer. The Scott & White Vasicek Cancer Treatment Center at Baylor Scott & White Medical Center – Temple offers an integrated care team for gastrointestinal cancers, including pancreatic cancer treatment.

Familial Risk Assessment Program

If your patients have an elevated risk for pancreatic cancer due to their family's genetic history, we can provide the proper clinical and genetic evaluation, education, care and support through our Pancreatic Cancer Familial Risk Assessment Program, part of Baylor Charles A. Sammons Cancer Center at Dallas.

The program can help assess your patient's level of risk for developing pancreatic cancer and help determine his or her risk to other family members.

Eligible patients include those with:

  • A personal history of pancreas cancer diagnosed at a young age
  • Two or more blood relatives with pancreas cancer – at least one first-degree relative
  • Peutz-Jeghers syndrome
  • Hereditary pancreatitis
  • BRCA 1 & 2 mutations with a family history of pancreas cancer
  • PALB2 mutation
  • Li-Fraumeni syndrome (p53 mutation)
  • Lynch Syndrome with a family history of pancreas cancer
  • Familial Atypical Multiple Mole and Melanoma syndrome (p16 mutation)

To learn more about the Pancreatic Cancer Familial Risk Assessment Program, call 214.820.3535.

Refer a Patient

Use our online tool to refer your patient to a hematology oncology specialist at Baylor Scott & White Health.

Hematology Oncology at Baylor Scott & White Health

Baylor Scott & White Health offers a multidisciplinary approach to cancer care – including tumor boards specialized by cancer type – to individualize your patient's treatment plan.

View all hematology oncology services